Dr. David Mark Otterburn, MD

Dr. Otterburn practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Otterburn's NPI, 1720261563, was assigned on December 16, 2007. Dr. Otterburn graduated from Rutgers Robert Wood Johnson Medical School in 2000. Dr. Otterburn holds New York license 257612.

Dr. Otterburn's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Otterburn's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Otterburn is also affiliated with Hospital for Special Surgery. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Otterburn to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Otterburn practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Otterburn's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Otterburn is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Otterburn's licenses on file in 3 states: New York, Georgia and Pennsylvania.

Dmand AI lists breast reconstruction, breast surgery, head wound and removal of damaged skin or skin graft among the conditions Dr. Otterburn treats.

CMS data shows 373 Medicare services from Dr. Otterburn across 8 procedure codes in 2024, for 166 Medicare patients. Medicare paid $175,372 for them.

CMS counts 166 Medicare patients who saw Dr. Otterburn in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high cholesterol, and 67% have arthritis. 17% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Otterburn's median patient age at 54, with 68% women.

In 2024, Dr. Otterburn wrote 14 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Otterburn for performance year 2024, reported through an alternative payment model (APM). Dr. Otterburn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Otterburn as offering telehealth. CMS counts 49 procedures of mastectomy by Dr. Otterburn, more than 94% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 96 papers to Dr. Otterburn, published from 2011 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Mammaplasty, Breast Neoplasms and Mastectomy. Dr. Otterburn has published most often in Ann Plast Surg. Dr. Otterburn's most frequent co-authors are Sophia Arbuiso, BS, Grant Garnett Black and S. Robert Rozbruch, MD.

Dmand AI links Dr. Otterburn to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 343 general payments to Dr. Otterburn from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. AxoGen paid the most, $8,973.

Dmand AI lists 2 awards for Dr. Otterburn, most recently Regional Top Doctor in 2014.

Dr. Otterburn graduated from Rutgers Robert Wood Johnson Medical School in 2000.

Dr. Otterburn is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.